Dr. Lal PathLabs Ltd (NSE:LALPATHLAB)
₹ 3053.05 52.65 (1.75%) Market Cap: 254.35 Bil Enterprise Value: 245.06 Bil PE Ratio: 62.28 PB Ratio: 12.49 GF Score: 100/100

Q4 2019 Dr. Lal PathLabs Ltd Earnings Call Transcript

May 17, 2019 / 10:30AM GMT
Release Date Price: ₹1065.35 (+2.31%)
Operator

Ladies and gentlemen, good day, and welcome to the Dr. Lal PathLabs Q4 and FY '19 Earning Conference Call. (Operator Instructions) Please note that this conference is being recorded. I would now like to hand the conference over to Mr. Nishid Solanki from CDR India. Thank you, and over to you, sir.

Nishid Solanki

Thank you. Good afternoon, everyone, and a warm welcome to Dr. Lal PathLabs Q4 and FY '19 Earnings Conference Call. Joining us today are Honorary Brigadier Dr. Arvind Lal, Chairman and Managing Director; Mr. Dr. Om Prakash Manchanda, Whole Time Director and CEO; Mr. C.A. Ved Goel, CFO. We also have with us Mr. Bharath, CEO, India business; and Mr. Rajat Kalra, Company Secretary and Head of Investor Relations.

Before we begin the call, I would like to highlight that some of the statements made on the call today could be forward-looking in nature. Actual results may vary significantly from these statements. A detailed disclosure in this regard is available in the results presentation which was circulated earlier.

I would now like to request Dr

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot